Global consulting and market research firm iData Research has released research on the European market for dental bone graft substitutes (DBGS) and other biomaterials.
The research provides insights into market trends, developments and competition through the firm’s methodology and analysis of over 50 companies across Europe.
According to iData’s 2023 European Dental Bone Graft Substitutes Suite of Market Reports, the overall market reached a valuation of just over €319.3m (US$384.7m) in 2022 and is projected to experience slight growth throughout the forecast period, reaching a value of over €411.6m (US$449.6m) by 2029 through a CAGR of 3.7%.
The report attributes the expansion of the overall market for DBGS and biomaterials to the consistent demand for dental implant procedures. Although the dental implant market is more advanced in Europe compared to the dental biomaterials market, the broader acceptance of dental grafts and biomaterials is on the rise due to advancements in dental implantology and the creation of novel treatment approaches.
Overall, the report projected that the long-term growth of the market will be driven by demographic factors, educational and technological development, consolidation and partnerships between dental companies and providers, as well as manufacturers focused on biomaterials and dental implant manufacturers.
iData’s analysis also includes detailed segmentation spanning across 10 countries — Germany, France, United Kingdom, Italy, Spain, Benelux, Scandinavia, Austria, Switzerland and Portugal — with segmentation coverage over the following markets: DBGS, dental growth factors, dental barrier membranes (DBMs), local antimicrobial periodontal treatment and dental soft tissue regeneration.
Also included in the report are insights into various aspects of the markets, including: unit sales, average selling prices, market drivers and limiters, competitive market share analysis and other relevant information.